Article
Towards Scalable Hospital-Based Palliative Care: Challenges and Opportunities for Hospitalists
1Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine at the University of Pennsylvania,...
Article
December 2018 Digital Edition
Article
Botulinum toxin: Emerging psychiatric indications
Botulinum toxin has shown promising antidepressant effects, and might be helpful for several other indications.
Article
Treating negative symptoms of schizophrenia
Few pharmacologic options, but evidence supports combining psychosocial interventions.
Article
The daunting challenge of schizophrenia: Hundreds of biotypes and dozens of theories
The heterogeneity of this complex brain syndrome represents a formidable challenge.
Article
A transgender adolescent with chronic pain, depression, and PTSD
X, a 17-year-old Mexican-American transgender male, experienced a traumatic brain injury 4 years ago and subsequently developed PTSD.
Article
Resilience: Our only remedy?
Resilience is like patience; we all wish we had more of it, but we hope to avoid getting it the hard way.
Article
Risperidone extended-release injectable suspension
RBP-7000 (Perseris) is the second long-acting injectable form of risperidone
approved in the United States.
Article
Catatonia: Recognition, management, and prevention of complications
Catatonia is associated with multiple medical complications that can result in death if unrecognized or unmanaged.
Article
Pharmacologic performance enhancement: What to consider before prescribing
Psychiatrists are increasingly finding themselves in the controversial position of 'gatekeeper' of these medications for enhancement purposes.